Inavolisib
ATC L01EM06 · 9 markets · 18 records
AU 3 records · 3 strengths
- 9 mgtabletITOVEBI inavolisib 3 mg film-coated tablet blister pack
- 3 mgtabletITOVEBI inavolisib 3 mg film-coated tablet blister pack
Records without a stated strength · 1 Itovebi
US 2 records · 2 strengths
GB 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
ES 2 records · 2 strengths
TW 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 Itovebi
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Itovebi
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 9 mg tablet | Itovebi | Itovebi | Itovebi | ITOVEBI inavolisib 3 mg film-coated tablet blister pack | Itovebi | Itovebi | Itovebi 癌妥飛9毫克膜衣錠 | ||
| 3 mg tablet | Itovebi | Itovebi | Itovebi | ITOVEBI inavolisib 3 mg film-coated tablet blister pack | Itovebi | Itovebi | Itovebi 癌妥飛3毫克膜衣錠 | ||
unknown | Itovebi | Itovebi | Itovebi |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.